A first-in-human phase I/II trial of SRA737 (a Chk1 Inhibitor) in subjects with advanced cancer
Plummer, ER Kristeleit, RS Cojocaru, E Haris, NM Carter, Louise Jones, RH Blagden, SP Evans, TRJ Arkenau, HT Sarker, D
Plummer, ER
Kristeleit, RS
Cojocaru, E
Haris, NM
Carter, Louise
Jones, RH
Blagden, SP
Evans, TRJ
Arkenau, HT
Sarker, D
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Plummer ER, Kristeleit RS, Cojocaru E, Haris NM, Carter L, Jones RH, et al. A first-in-human phase I/II trial of SRA737 (a Chk1 Inhibitor) in subjects with advanced cancer. J Clin Oncol. 2019;37(15_suppl):3094-.